Jazz brings the noise to the FDA with lawsuit over approval of Avadel's narcolepsy drug Lumryx
Fierce Pharma
JUNE 23, 2023
After years of using the patent system to delay competition from a rival company and then exhausting that ploy early this year, Jazz Pharmaceuticals is taking a new route—suing the FDA.
240 
Let's personalize your content